C12N 2710/16052
Relating to complementing cells and packaging systems for producing virus or viral
Official title: relating to complementing cells and packaging systems for producing virus or viral particles
C12N2710/16052 (Relating to complementing cells and packaging systems for producing virus or viral) appears on 4 US grants and 10 published applications in this corpus.
Search patents in C12N- Granted patents
- 4
- Published applications
- 10
- Assignees
- 11
- Inventors
- 33
- Latest grant
- 12 Jul 2022
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2002 | 0 | 1 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 1 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 1 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 1 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 1 | 0 |
| 2015 | 0 | 0 |
| 2016 | 0 | 1 |
| 2017 | 1 | 0 |
| 2018 | 0 | 0 |
| 2019 | 1 | 1 |
| 2020 | 0 | 0 |
| 2021 | 0 | 0 |
| 2022 | 1 | 0 |
| 2023 | 0 | 0 |
| 2024 | 0 | 1 |
| 2025 | 0 | 2 |
| 2026 | 0 | 1 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- EHV with inactivated UL18 and/or UL812 Jul 2022US 11,384,365 B2
- Compositions and methods for the production of alpha-herpesviruses17 Dec 2019US RE47,768 E1Sanofi Pasteur Biologics, LLC
- Cyprinid herpesvirus II-sensitive brain tissue cell line of Carassius auratus gibelio and establishing method and use thereof21 Mar 2017US 9,598,671 B2Yangtze River Fisheries Research Institute, Chinese Academy of Fishery Sciences
- Compositions and methods for the production of alpha-herpesviruses4 Nov 2014US 8,877,492 B2Sanofi Pasteur Biologics, LLC
- Adeno-Associated Virus Production Platform9 Jul 2026US 2026/0193676 A1MedImmune, LLC
- Modified Herpes Simplex Virus Type 16 Nov 2025US 2025/0340903 A1Eg 427
- Plasmid dna purification methods1 May 2025US 2025/0137024 A1Glaxosmithkline Biologicals SA
- Kaposi sarcoma associated herpesvirus gene function25 Jul 2024US 2024/0248080 A1The Regents of the University of California
- Ehv with inactivated ul18 and/or ul819 Sep 2019US 2019/0284577 A1Boehringer Ingelheim Vetmedica GmbH
Most cited
By later US patents